Procainamide

CHEMBL640 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

235.3 g/mol

LogP

0.9

Phase

4

Used to treat certain abnormal heart rhythms (arrhythmias) by slowing electrical conduction in the heart and making the heart muscle less excitable. It requires careful monitoring because long-term use can cause a lupus-like syndrome and other serious side effects.

Berat Molekul

235,3300 g/mol

LogP

0,90

TPSA

58,40 Å²

Lipinski RO5

Lulus

Area Terapeutik

Cardiovascular Disease Breast Cancer Heart Failure Atrial Fibrillation Prostate Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCN(CC)CCNC(=O)c1ccc(N)cc1

InChI

InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)

Molecular Formula

C13H21N3O

HBD / HBA

2 / 3

Ikatan yang Dapat Dirotasi

6

Atom Berat

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Used to treat certain abnormal heart rhythms (arrhythmias) by slowing electrical conduction in the heart and making the heart muscle less excitable. It requires careful monitoring because long-term use can cause a lupus-like syndrome and other serious side effects.

Yes, Procainamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL640. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4913. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Procainamide di PillFYI

Struktur

Data Cepat

Rumus: C13H21N3O

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.